Promising results for nivolumab in advanced liver cancer

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Incidences of liver cancer rising in the USA

The role of health economics in cancer outcomes research

Biobanking biological materials and linkage to clinical information

2nd EurocanPlatform translational research course is good for networking

Reasons to attend the EurocanPlatform translational research course 2015

Immunotherapy of cancer: recent progress and future challenges

Epigenome deregulation in cancer

Aims and successes of the 2nd EurocanPlatform project translational research course